These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 22010353)
1. [The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients]. Deng CH; Zhang GM; Bi SS; Zhou TY; Lu W Yao Xue Xue Bao; 2011 Jul; 46(7):828-33. PubMed ID: 22010353 [TBL] [Abstract][Full Text] [Related]
2. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients. Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583 [TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus. Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655 [TBL] [Abstract][Full Text] [Related]
5. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Staatz CE; Tett SE Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation. Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Staatz CE; Willis C; Taylor PJ; Tett SE Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747 [TBL] [Abstract][Full Text] [Related]
8. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of limited sampling strategies for tacrolimus. Op den Buijsch RA; van de Plas A; Stolk LM; Christiaans MH; van Hooff JP; Undre NA; van Dieijen-Visser MP; Bekers O Eur J Clin Pharmacol; 2007 Nov; 63(11):1039-44. PubMed ID: 17712551 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of tacrolimus: a moving matter. Manzanares C Therapie; 2002; 57(2):133-6. PubMed ID: 12185961 [TBL] [Abstract][Full Text] [Related]
11. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study. Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042 [TBL] [Abstract][Full Text] [Related]
13. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Pascual J; del Castillo D; Cabello M; Pallardó L; Grinyó JM; Fernández AM; Brunet M Transplantation; 2010 Apr; 89(8):994-1000. PubMed ID: 20335831 [TBL] [Abstract][Full Text] [Related]
14. Making every drop count for pediatric kidney transplant patients. Clark SL; Taylor A; Shaw KN; Copelovitch L Hosp Pediatr; 2015 May; 5(5):287-9. PubMed ID: 25934814 [No Abstract] [Full Text] [Related]
15. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients. Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156 [TBL] [Abstract][Full Text] [Related]
17. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant]. Xue L; Rui JZ; Zhang Y; Miao LY Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140 [TBL] [Abstract][Full Text] [Related]
18. Improved pharmacokinetic monitoring of tacrolimus exposure after pediatric renal transplantation. Lee MN; Butani L Pediatr Transplant; 2007 Jun; 11(4):388-93. PubMed ID: 17493218 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients. Riff C; Debord J; Monchaud C; Marquet P; Woillard JB Br J Clin Pharmacol; 2019 Aug; 85(8):1740-1750. PubMed ID: 30973981 [TBL] [Abstract][Full Text] [Related]
20. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]